Patients with inflammatory bowel disease who also had non-alcoholic fatty liver disease had higher readmission rates, according to research presented at Crohn’s and Colitis Congress.

“NAFLD is highly prevalent in IBD patients,” Shaya Noorian, MD, of the University of California, Los Angeles, said in his presentation. “Currently, there is a paucity of data examining the impact of NAFLD on clinical outcomes in IBD patients.”

Researchers conducted a propensity-score matched study using data from the Nationwide Readmissions Database from 2016 to 2017. They identified

Full Article: